We are in the process of upgrading our site. Please kindly cooperate with us.

Published Articles

215,213

Total Articles

285,213

Happy users

1,459,539

Open Access JournalsView More

Medical

Editors-in-Chief View More

Journal of Applied Engineering Education
DR ADIL HAKEEM KHAN, MBA PhD
Editor-in-Chief
DIRECTOR, RESEARCH
Aeero (Aarav Educational & Employment Research Organization) (Affiliated by Guru GobindSingh Indraprastha University Dwarka, New Delhi.), Dwarka, New Delhi India, DELHI, India
International Journal of Media and Networks
Osamah Ibrahim Khalaf, PhD
Editor-in-Chief
assistant Professor.., Al-Nahrain Renewable Energy Research Centre Iraq
Al-Nahrain University - Baghdad, Iraq. , Baghdad, Iraq
Biomedical Science and Clinical Research
Hossein Hosseinkhani
Editor-in-Chief
Shareholder & Owner, Innovation Center for Advanced Technology Matrix, Inc.
USA
Current Research in Statistics & Mathematics
Ferit G, PHD
Editor-in-Chief
Associate Professor, Department of Mathematics
Kırklareli University, Kırklareli, Turkey
General Surgery and Clinical Medicine
Mojtaba Esmailpour Roshan, Dvm,Phd
Editor-in-Chief
Researcher and Lecturer at Payam Noor University of Iran, General Surgery Cancer research ,Veterinary medicine
Islamic Azad University of Garmsar,iran, SEMNAN, IR Iran
International Journal of Nanotechnology and Nanomedicine
Sajjad babaei, PhD
Editor-in-Chief
Professor, Department of nanotechnology
Insitute of the pastokovak, Tehran , Iran

Latest Articles from "Opast Publisher"

Research Article     Free Accress

Is Sentinel Lymph Node Tumor Burden a Prognostic Factor for Disease-Free Survival in Patients with Melanoma of the Trunk and Extremities?

Carlos Lehmann-Mosquera, Raul Suarez-Rodriguez, Patricia Lopez-Correa, Ricardo Sanchez, Samuel David Morales, Mau-ricio Garcia-Mora, Javier Angel-Aristizabal, Ivan Marino-Lozano, Carlos Alfonso Duarte-Torres and Sandra E. Diaz-Casas

International Journal of Cancer Research & Therapy

Research Article     Free Accress

Is Sentinel Lymph Node Tumor Burden a Prognostic Factor for Disease-Free Survival in Patients with Melanoma of the Trunk and Extremities?

Carlos Lehmann-Mosquera, Raul Suarez-Rodriguez, Patricia Lopez-Correa, Ricardo Sanchez, Samuel David Morales, Mau-ricio Garcia-Mora, Javier Angel-Aristizabal, Ivan Marino-Lozano, Carlos Alfonso Duarte-Torres and Sandra E. Diaz-Casas

International Journal of Cancer Research & Therapy

Research Article     Free Accress

Outcomes of Brentuximab Vedotin with or without Bendamustine and Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma: An Early Experience from Patient Access Programme in India

Jyothi Goutham, Samrudhi Joshi, Shekar Patil, Satheesh Chiradoni Thungappa, Ravi Thippeswamy, Shashidha-ra HP, Nishit Ojha, Amey C Panchal, Yesheswini N Naik, Jayantha Balawardane and Sachin Suresh Jadhav

Advances in Hematology and Oncology Research

Research Article     Free Accress

Outcomes of Brentuximab Vedotin with or without Bendamustine and Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma: An Early Experience from Patient Access Programme in India

Jyothi Goutham, Samrudhi Joshi, Shekar Patil, Satheesh Chiradoni Thungappa, Ravi Thippeswamy, Shashidha-ra HP, Nishit Ojha, Amey C Panchal, Yesheswini N Naik, Jayantha Balawardane and Sachin Suresh Jadhav

Advances in Hematology and Oncology Research

List of Pubmed Articles